Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of ViroPharma Incorporated Stockholders
14 November 2013 - 9:11AM
Business Wire
Kirby McInerney LLP is investigating potential claims against
the Board of Directors of ViroPharma Incorporated (“ViroPharma” or
the “Company”) (NASDAQ:VPHM) concerning the proposed acquisition of
the Company by Shire plc (“Shire”). Under the terms of the proposed
transaction, ViroPharma stockholders will receive $50.00 in cash
for each share of ViroPharma owned, valuing the transaction at
approximately $4.2 billion.
The investigation concerns whether the ViroPharma Board of
Directors violated its fiduciary duties by agreeing to the proposed
transaction and whether the $50.00 per share proposed consideration
adequately values ViroPharma’s common stock.
If you are a ViroPharma stockholder and wish to obtain
additional information, please contact J. Brandon Walker, Esq.
by email at bwalker@kmllp.com, by telephone at (212) 699-1145 or
(888) 529-4787, or by filling out this contact form. There is no
cost or obligation to you.
Kirby McInerney LLP is a New York-based law firm concentrating
in securities, stockholder, whistleblower, antitrust and consumer
litigation. For additional information, please go to
www.kmllp.com.
Kirby McInerney LLPJ. Brandon Walker, Esq.,
212-699-1145888-529-4787bwalker@kmllp.com
Viropharma Incorporated (MM) (NASDAQ:VPHM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Viropharma Incorporated (MM) (NASDAQ:VPHM)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Viropharma Incorporated (MM) (NASDAQ): 0 recent articles
More Viropharma Incorporated (MM) News Articles